Implantable Cardiac Monitor (ICM)

Implantable cardiac monitors (ICM) are small electrophysiology (EP) devices that used for long-term monitoring of a patient's heart electrical activity to detect arrhythmias. The technology can eliminate the need for a bulkly external Holter monitor that requires wire leads attached to the patient. ICMs can be inserted under the skin during and office visit and record cardiac data continuously for up to 4.5 years.

Rutgers study finds post-surgical hospitalization rates from left ventricular assist devices varied by socioeconomic factors

News | Heart Failure

Lower-Income Patients with Heart Pumps More Likely Hospitalized with Major Bleeding, Infection or Heart Failure

October 6, 2022 — The complications experienced by heart failure patients implanted with a left ventricular assist ...

October 06, 2022

The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population

News | Pediatric Cardiology

Medtronic Receives FDA Clearance for Expanded Indication of LINQ II Insertable Cardiac Monitor For Use in Pediatric Patients Ages 2 and Older

September 20, 2022 — Medtronic, a global leader in healthcare technology, today announced the LINQ II Insertable Cardiac ...

September 20, 2022

With the increase of patients experiencing heart failure and clinical challenges to manage advanced heart failure conditions, therapies with implantable devices have become an essential treatment method

Feature | Heart Failure | By Jean-Luc Boulnois, Ph.D.

Effectively Treating Heart Failure: New Technology on the Horizon

The current standard of care for heart failure (HF) is guideline-directed medical therapy combined with device-based ...

May 04, 2022

News | Magnetic Resonance Imaging (MRI)

Remote Programming of Cardiac Implantable Devices is Safe for MRI Scan

May 4, 2022 — More than 60 million magnetic resonance imaging (MRI) scans are performed worldwide each year, but imaging ...

May 04, 2022

Medtronic has announced new data from the STROKE AF clinical trial, which showed that large and small vessel ischemic stroke patients who receive short-term or intermittent monitoring (i.e., Holter monitors and 30-day external monitors) may not be optimally managed for recurrent stroke prevention versus those who received continuous monitoring with insertable cardiac monitors.

News | Implantable Cardiac Monitor (ICM)

New Simulation Data From the STROKE AF Study Shows Insertable Cardiac Monitors Detect 4 Times More AF than Intermittent Monitoring

April 29, 2022 – Medtronic has announced new data from the STROKE AF clinical trial, which showed that large and small ...

April 29, 2022

Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of patients with non-ST segment elevation myocardial infarction (NSTEMI).

News | Implantable Cardiac Monitor (ICM)

Insertable Cardiac Monitors (ICM) and Remote Monitoring May Improve Outcomes for Post-Myocardial Infarction Patients, Study Demonstrates

April 6, 2022 – Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of ...

April 06, 2022

News | Heart Failure

Abbott’s CardioMEMS HF System Receives FDA Approval to Support Patients Battling Earlier-Stage Heart Failure

February 25, 2022 – Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an expanded ...

February 25, 2022

FDA clears Implicity algorithm to reduce the volume of false positives from Medtronic implantable loop recorders by nearly 80%

News | Remote Monitoring

FDA Clears AI-Powered ECG Analyzer for Implantable Loop Recorders

January 4, 2022 – Remote patient monitoring and cardiac data management solutions vendor Implicity received U.S. Food ...

January 04, 2022

The Medtronic Linq II implantable cardiac monitor.

News | Atrial Fibrillation

Continuous Heart Rhythm Monitoring and Anticoagulation Does Not Prevent Stroke

September 8, 2021 — Continuous heart rhythm monitoring – with anticoagulation if atrial fibrillation is detected – does ...

September 08, 2021

The Medtronic Reveal Linq implantable cardiac monitor (ICM) was used in the SMART-MI study. It is inserted under the skin in a simple, fast outpatient procedure. The device is smaller than a AAA battery.

News | Implantable Cardiac Monitor (ICM)

Implantable Cardiac Monitors Predict Complications in Selected Post-myocardial Infarction Patients

September 7, 2021 — Remote monitoring of implantable cardiac monitors (ICMs) is highly effective for early detection of ...

September 07, 2021

BioMonitor IIIm is a miniature electrocardiogram (ECG) device which records, stores and transmits clinical data that is integral in the diagnosis and long-term monitoring of cardiac patients, with maximum precision and for an extended period of time.

News | Implantable Cardiac Monitor (ICM)

Biotronik Implantable Cardiac Monitor Receives Prestigious Industry Award

August 9, 2021 - In association with Heart Rhythm 2021, Biotronik today announced that the latest implantable cardiac ...

August 09, 2021

In the past decade there has been a proliferation of clinical-grade wearable monitors and implantable devices such as pacemakers, ICDs, implantable cardiac monitors, and new pacemaker-like devices that can control hypertension. In the near future, these devices will be tied into a body-wide internet of things for specific patients that can transmit patient data to clinicians wirelessly to enable an integrated, more robust form of telecardiology and telemedicine.

Feature | Telecardiology | Victor Wollesen

Next Generation Cardiac Wearables and Implantables Will Integrate Into Wireless Body Area Networks

Cardiovascular diseases are among the leading causes of death for people over 65 years old in North America and Europe ...

July 23, 2021

Medtronic announced clinical trial results from the STROKE AF trial demonstrating the superiority of the Reveal Linq Insertable Cardiac Monitor (ICM) to detect abnormal heartbeats, otherwise known as atrial fibrillation (AF), in both large and small vessel stroke patients compared to standard of care.

News | Implantable Cardiac Monitor (ICM)

Medtronic Insertable Cardiac Monitor Detects Significantly Higher Rates of Atrial Fibrillation in Large and Small Vessel Stroke Patients Compared to Standard of Care

June 13, 2021 — Medtronic announced clinical trial results from the STROKE AF trial demonstrating the superiority of the ...

July 14, 2021

The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device

News | Cardiac Diagnostics

FDA Approves AngelMed Enhanced Real-Time Cardiac Monitor for Acute Coronary Syndrome (ACS) Events

July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation ...

July 01, 2021

Implicity provides a remote cardiac monitoring and research platform used by Independent Diagnostic Testing Facilities and medical centers to deliver high-quality care for patients with connected cardiac devices. On this platform, Implicity aggregates, normalizes and standardizes data from any implantable cardiac device across all manufacturers.

News | EP Lab

Implicity Signs U.S. Distribution Agreement With MicroPort CRM to Expand Remote Monitoring of Various Implanted Cardiac Devices

June 2, 2021 — Implicity, a leader in remote patient monitoring software and cardiac data management solutions ...

June 02, 2021